Retraction Note: The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients
Cancer Gene Therapy, Published online: 22 June 2022; doi:10.1038/s41417-022-00496-9Retraction Note: The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 22, 2022 Category: Cancer & Oncology Authors: Rady E. El-Araby Mahmoud A. Khalifa Mona M. Zoheiry Manal Y. Zahran Mohamed I. Rady Raafat A. Ibrahim Mohamed D. El-Talkawy Faiza M. Essawy Source Type: research
Lnc-ABCA12-8 confers acquired resistance to gefitinib in non-small cell lung cancer by regulating the alternative splicing of fibronectin 1 in the IIICS region
Cancer Gene Therapy, Published online: 14 June 2022; doi:10.1038/s41417-022-00483-0Lnc-ABCA12-8 confers acquired resistance to gefitinib in non-small cell lung cancer by regulating the alternative splicing of fibronectin 1 in the IIICS region (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 14, 2022 Category: Cancer & Oncology Authors: Shuai He Jingjing Shi HongHao Zhou Qingling Li Lanxiang Wu Source Type: research
Regional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibition
Cancer Gene Therapy, Published online: 14 June 2022; doi:10.1038/s41417-022-00484-zRegional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibition (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 14, 2022 Category: Cancer & Oncology Authors: Chandra C. Ghosh Kara R. Heatherton Kyle P. O ’ Connell Ian S. Alexander Deborah A. Greer Jason LaPorte Prajna Guha Bryan F. Cox Steven C. Katz Source Type: research
Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells
Cancer Gene Therapy, Published online: 09 June 2022; doi:10.1038/s41417-022-00486-xActivation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 9, 2022 Category: Cancer & Oncology Authors: Ilan Zaffran Nadine Landolina Pratibha Gaur Tihana Lenac Rovis Jonjic Stipan Ofer Mandelboim Bernhard B. Singer Francesca Levi-Schaffer Source Type: research
Extracellular sialyltransferase st6gal1 in breast tumor cell growth and invasiveness
Cancer Gene Therapy, Published online: 08 June 2022; doi:10.1038/s41417-022-00485-yExtracellular sialyltransferase st6gal1 in breast tumor cell growth and invasiveness (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 8, 2022 Category: Cancer & Oncology Authors: Nitai C. Hait Aparna Maiti Rongrong Wu Valerie L. Andersen Chang-Chieh Hsu Yun Wu Digantkumar G. Chapla Kazuaki Takabe Michael E. Rusiniak Wiam Bshara Jianmin Zhang Kelley W. Moremen Joseph T. Y. Lau Source Type: research
